Differential expression of RAGE in human pancreatic carcinoma cells

Hepato-Gastroenterology

Volumn 48, Issue 42, 2001, Pages 1577-1578

  Takada, M ^a   Koizumi, T ^a   Toyama, H ^a   Suzuki, Y ^a   Kuroda, Y ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer; Pancreas; RAGE

Indexed keywords

CELL SURFACE PROTEIN; PROTEIN RAGE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; HUMAN; HUMAN CELL; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; WESTERN BLOTTING;

BLOTTING, WESTERN; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; RECEPTORS, IMMUNOLOGIC; TUMOR CELLS, CULTURED;

EID: 0035658461     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Isolation and characterization of binding proteins for advanced glycation end products from lung tissue which are present on the endothelial cell surface
2. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
3. Blockade of RAGE-amphoterin signaling suppresses tumor growth and metastasis
4. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways
5. The nuclear factor-kappa B RelA transcriptional factor is constitutively activated in human pancreatic adenocarcinoma cells
6. The expression of chemokine genes correlates with nuclear factor-kappaB activation in human pancreatic cancer cell lines
7. Checkpoint for invasion
8. Chronologically-specific metastatic targeting of human pancreatic tumors in orthotopic models
9. Down-regulation of E-cadherin gene expression by collagen type I and III in pancreatic cancer cell lines
10. Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility